Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]
OMNY Health has reached a major milestone, announcing that its [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
As oncology research continues to evolve, the focus is increasingly [...]